CVS Health Corporation
CVS Health Corporation (CVS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CVS · as of Jun 9, 2026
Key Statistics
Explore CVS Health Corporation Data
cvs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 85.4%
The CVS analyst consensus is Buy, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $103.08, representing +6.18% upside from the current price of $97.08.
Competitors & Peers
cvs competitorsCVS
BMY
CI
COR
ELV
GSKStock Performance
Full HistoryAbout CVS Health Corporation
CVS Health Corporation is a prominent healthcare services provider operating across the United States. The company's Health Care Benefits division delivers a range of health insurance offerings, inclu…
what is cvs health corporation · cvs stock overview · cvs health corporation company profile · who is cvs health corporation ceo · cvs NYSE · cvs health corporation headquarters · cvs health corporation business segments
About Stock Overview & Key Data
CVS Health Corporation (CVS) is a Healthcare company in the Medical - Healthcare Plans industry, listed on NYSE since Nov 20, 1996. As of the latest trading session, CVS stock price is $97.08, with a market capitalization of $123.9B. The stock has returned +50.22% over the past 12 months and +20.88% year-to-date.
According to 41 Wall Street analysts, the consensus rating for CVS Health Corporation stock is Buy, with an average 12-month price target of $103.08. In fiscal year 2025, CVS Health Corporation reported revenue of $402.1B and net income of $1.8B. For detailed data — including CVS Health Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CVS Health Corporation (CVS) stock price is $97.08. The stock is traded on NYSE under the ticker symbol CVS. The 52-week range is $58.50 – $98.43.